wang zhen zhong - Net Worth and Insider Trading

wang zhen zhong Net Worth

The estimated net worth of wang zhen zhong is at least $5 Million dollars as of 2024-06-22. wang zhen zhong is the Director of Jiangsu Kanion Pharmaceutical Co Ltd and owns about 300,000 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) stock worth over $5 Million. Details can be seen in wang zhen zhong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that wang zhen zhong has not made any transactions after 2022-09-26 and currently still holds the listed stock(s).

Transaction Summary of wang zhen zhong

To

wang zhen zhong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, wang zhen zhong owns 1 companies in total, including Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) .

Click here to see the complete history of wang zhen zhong’s form 4 insider trades.

Insider Ownership Summary of wang zhen zhong

Ticker Comapny Transaction Date Type of Owner
SHSE:600557 Jiangsu Kanion Pharmaceutical Co Ltd 2022-09-26 Director

wang zhen zhong Latest Holdings Summary

wang zhen zhong currently owns a total of 1 stock. wang zhen zhong owns 300,000 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) as of September 26, 2022, with a value of $5 Million.

Latest Holdings of wang zhen zhong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600557 Jiangsu Kanion Pharmaceutical Co Ltd 2022-09-26 300,000 16.10 4,830,000

Holding Weightings of wang zhen zhong


wang zhen zhong Form 4 Trading Tracker

According to the SEC Form 4 filings, wang zhen zhong has made a total of 1 transactions in Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Jiangsu Kanion Pharmaceutical Co Ltd is the sale of 300,000 shares on September 26, 2022, which brought wang zhen zhong around $2 Million.

Insider Trading History of wang zhen zhong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

wang zhen zhong Trading Performance

GuruFocus tracks the stock performance after each of wang zhen zhong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by wang zhen zhong is 44.67%. GuruFocus also compares wang zhen zhong's trading performance to market benchmark return within the same time period. The performance of stocks bought by wang zhen zhong within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how wang zhen zhong's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of wang zhen zhong

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 54.26 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 49.46 LIMIT LIMIT LIMIT LIMIT LIMIT

wang zhen zhong Ownership Network

Ownership Network List of wang zhen zhong

No Data

Ownership Network Relation of wang zhen zhong

Insider Network Chart

wang zhen zhong Owned Company Details

What does Jiangsu Kanion Pharmaceutical Co Ltd do?

Who are the key executives at Jiangsu Kanion Pharmaceutical Co Ltd?

wang zhen zhong is the Director of Jiangsu Kanion Pharmaceutical Co Ltd. Other key executives at Jiangsu Kanion Pharmaceutical Co Ltd include and senior management Wan Yan Huan .

Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jiangsu Kanion Pharmaceutical Co Ltd Insider Transactions

No Available Data

wang zhen zhong Mailing Address

Above is the net worth, insider trading, and ownership report for wang zhen zhong. Currently GuruFocus does not have mailing address information for wang zhen zhong.

Discussions on wang zhen zhong

No discussions yet.